• 1
    Amor, S., Groome, N., Linington, C., Morris, M. M., Dornmair, K., Gardinier, M. V., Matthieu, J. M. and Baker, D., Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 1994. 153: 43494356.
  • 2
    Morris-Downes, M. M., McCormack, K., Baker, D., Sivaprasad, D., Natkunarajah, J. and Amor, S., Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice. J. Neuroimmunol. 2002. 122: 2033.
  • 3
    Thoua, N. M., van Noort, J. M., Baker, D., Bose, A., van Sechel, A. C., van Stipdonk, M. J., Travers, P. J. and Amor, S., Encephalitogenic and immunogenic potential of the stress protein alphaB-crystallin in Biozzi ABH (H-2A(g7)) mice. J. Neuroimmunol. 2000. 104: 4757.
  • 4
    Furlan, R., Brambilla, E., Sanvito, F., Roccatagliata, L., Olivieri, S., Bergami, A., Pluchino, S., Uccelli, A., Comi, G. and Martino, G., Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57BL/6 mice. Brain 2003. 126: 285291.
  • 5
    Slavin, A. J., Johns, T. G., Orian, J. M. and Bernard, C. C., Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Dev. Neurosci. 1997. 19: 6978.
  • 6
    Brunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J. M. and Linington, C., Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J. Neurochem. 1989. 52: 296304.
  • 7
    Scolding, N. J., Frith, S., Linington, C., Morgan, B. P., Campbell, A. K. and Compston, D. A., Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation. J. Neuroimmunol. 1989. 22: 169176.
  • 8
    Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A. and Linington, C., T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 2001. 36: 220234.
  • 9
    Delarasse, C., Daubas, P., Mars, L. T., Vizler, C., Litzenburger, T., Iglesias, A., Bauer, J., Della Gaspera, B., Schubart, A., Decker, L. et al., Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J. Clin. Invest. 2003. 112: 544553.
  • 10
    Lyons, J. A., San, M., Happ, M. P. and Cross, A. H., B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 1999. 29: 34323439.
  • 11
    Adelmann, M., Wood, J., Benzel, I., Fiori, P., Lassmann, H., Matthieu, J. M., Gardinier, M. V., Dornmair, K. and Linington, C., The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 1995. 63: 1727.
  • 12
    Brok, H. P., Uccelli, A., Kerlero De Rosbo, N., Bontrop, R. E., Roccatagliata, L., de Groot, N. G., Capello, E., Laman, J. D., Nicolay, K., Mancardi, G. L. et al., Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24–36 is presented by a monomorphic MHC class II molecule. J. Immunol. 2000. 165: 10931101.
  • 13
    Kerlero de Rosbo, N., Brok, H. P., Bauer, J., Kaye, J. F., ‘t Hart, B. A. and Ben-Nun, A., Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: characterisation of immunodominant T- and B-cell epitopes. J. Neuroimmunol. 2000. 110: 8396.
  • 14
    van der Goes, A., Kortekaas, M., Hoekstra, K., Dijkstra, C. D. and Amor, S., The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages. J. Neuroimmunol. 1999. 101: 6167.
  • 15
    Morris-Downes, M. M., Smith, P. A., Rundle, J. L., Piddlesden, S. J., Baker, D., Pham-Dinh, D., Heijmans, N. and Amor, S., Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice. J. Neuroimmunol. 2002. 125: 114124.
  • 16
    Baker, D., O'Neill, J. K., Gschmeissner, S. E., Wilcox, C. E., Butter, C. and Turk, J. L., Induction of chronic relapsing experimental allergic encephalomyelitis in mice. J. Neuroimmunol. 1990. 28: 261270.
  • 17
    van Noort, J. M., El Ouagmiri, M., Boon, J. and van Sechel, A. C., Fractionation of central nervous system myelin proteins by reversed phase high-performance liquid chromatography. J. Chromatogr. 1994. 653: 155161.
  • 18
    Lehmann, P. V., Forsthuber, T., Miller, A. and Sercarz, E. E., Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992. 358: 155157.
  • 19
    McRae, B. L., Vanderlugt, C. L., Dal Canto, M. C. and Miller, S. D., Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 1995. 182: 7585.
  • 20
    Yu, M., Johnson, J. M. and Tuohy, V. K., Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. J. Neurosci. Res. 1996. 45: 463470.
  • 21
    Kumar, V., Determinant spreading during experimental autoimmune encephalomyelitis: is it potentiating, protecting or participating in the disease? Immunol. Rev. 1998. 164: 7380.
  • 22
    Vanderlugt, C. L., Neville, K. L., Nikcevich, K. M., Eagar, T. N., Bluestone, J. A. and Miller, S. D., Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J. Immunol. 2000. 164: 670678.
  • 23
    Tuohy, V. K., Yu, M., Yin, L., Kawczak, J. A. and Kinkel, P. R., Regression and spreading of self-recognition during the development of autoimmune demyelinating disease. J. Autoimmun. 1999. 13: 1120.
  • 24
    Tuohy, V. K., Yu, M., Weinstock-Guttman, B. and Kinkel, R. P., Diversity and plasticity of self recognition during the development of multiple sclerosis. J. Clin. Invest. 1997. 99: 16821690.
  • 25
    Yu, M., Kinkel, R. P., Weinstock-Guttman, B., Cook, D. J. and Tuohy, V. K., HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Hum. Immunol 1998. 59: 1524.
  • 26
    Amor, S., O'Neill, J. K., Morris, M. M., Smith, R. M., Wraith, D. C., Groome, N., Travers, P. J. and Baker, D., Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif. J. Immunol. 1996. 156: 30003008.
  • 27
    Amor, S., Baker, D., Groome, N. and Turk, J. L., Identification of a major encephalitogenic epitope of proteolipid protein (residues 56–70) for the induction of experimental allergic encephalomyelitis in AB/H and nonobese diabetic mice. J. Immunol. 1993. 150: 56665672.
  • 28
    Cserr, H. F. and Knopf, P. M., Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today 1992. 13: 507512.
  • 29
    Wenkel, H., Streilein, J. W. and Young, M. J., Systemic immune deviation in the brain that does not depend on the integrity of the blood-brain barrier. J. Immunol. 2000. 164: 51255131.
  • 30
    Linares, D., Mana, P., Goodyear, M., Chow, A. M., Clavarino, C., Huntington, N. D., Barnett, L., Koentgen, F., Tomioka, R., Bernard, C. et al., The magnitude and encephalogenic potential of autoimmune response to MOG is enhanced in MOG deficient mice. J. Autoimmun. 2003. 21: 339351.
  • 31
    Carotenuto, A., D'Ursi, A. M., Nardi, E., Papini, A. M. and Rovero, P., Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis. J. Med. Chem. 2001. 44: 23782381.
  • 32
    Mazzucco, S., Mata, S., Vergelli, M., Fioresi, R., Nardi, E., Mazzanti, B., Chelli, M., Lolli, F., Ginanneschi, M., Pinto, F. et al., A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. Bioorg. Med. Chem. Lett. 1999. 9: 167172.
  • 33
    Oliver, A. R., Lyon, G. M. and Ruddle, N. H., Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 2003. 171: 462468.
  • 34
    Abo, S., Bernard, C. C., Webb, M., Johns, T. G., Alafaci, A., Ward, L. D., Simpson, R. J. and Kerlero de Rosbo, N., Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Biochem. Mol. Biol. Int. 1993. 30: 945958.
  • 35
    Abdul-Majid, K. B., Jirholt, J., Stadelmann, C., Stefferl, A., Kjellen, P., Wallstrom, E., Holmdahl, R., Lassmann, H., Olsson, T. and Harris, R. A., Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J. Neuroimmunol. 2000. 111: 2333.
  • 36
    Johns, T. G., Kerlero de Rosbo, N., Menon, K. K., Abo, S., Gonzales, M. F. and Bernard, C. C., Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 1995. 154: 55361541.
  • 37
    Devaux, B., Enderlin, F., Wallner, B. and Smilek, D. E., Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide. J. Neuroimmunol. 1997. 75: 169173.
  • 38
    Hughes, L. E., Smith, P. A., Bonell, S., Natt, R. S., Wilson, C., Rashid, T., Amor, S., Thompson, E. J., Croker, J. and Ebringer, A., Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J. Neuroimmunol. 2003. 144: 105115.
  • 39
    Becker, C., Della Gaspera, B., Guyot, M., Donsez, E., Armand, A. S., Charbonnier, F., Launay, T. and Chanoine, C., Expression of MRF4 protein in adult and in regenerating muscles in Xenopus. Dev. Dyn. 2003. 227: 445449.
  • 40
    van Noort, J. M., van Sechel, A. C., Bajramovic, J. J., el Ouagmiri, M., Polman, C. H., Lassmann, H. and Ravid, R., The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995. 375: 798801.